Momenta Phama (MNTA), Baxalta (BXLT) ANnounce M923 Met Primary Endpoint vs. HUMIRA
Tweet Send to a Friend
Baxalta Incorporated (NYSE: BXLT) and Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), announced that M923 met the primary endpoint in a randomized ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
